ACADIAN ASSET MANAGEMENT LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$171
-76.4%
1,915
-77.5%
0.00%
-66.7%
Q2 2023$724
-46.0%
8,504
-47.7%
0.00%
-50.0%
Q1 2023$1,341
+8.7%
16,247
+3.4%
0.01%0.0%
Q4 2022$1,234
-98.4%
15,717
+1395.4%
0.01%
Q3 2022$77,000
+108.1%
1,051
+219.5%
0.00%
Q1 2021$37,000
-5.1%
3290.0%0.00%
Q4 2020$39,000
+34.5%
3290.0%0.00%
Q3 2020$29,000
-99.3%
329
-99.3%
0.00%
-100.0%
Q2 2020$4,290,000
-49.1%
47,911
-43.3%
0.02%
-62.5%
Q1 2020$8,426,000
-5.0%
84,549
+9.5%
0.05%
+20.0%
Q4 2019$8,870,000
-33.4%
77,198
-26.9%
0.04%
-29.8%
Q3 2019$13,327,000
-49.6%
105,639
-51.9%
0.06%
-55.1%
Q2 2019$26,449,000
-24.2%
219,785
-44.9%
0.13%
-15.3%
Q1 2019$34,871,000
-48.3%
398,642
-40.9%
0.15%
-55.1%
Q4 2018$67,473,000
-24.5%
674,407
-13.5%
0.33%
-9.5%
Q3 2018$89,314,000
+12.1%
779,498
-12.2%
0.37%
+7.3%
Q2 2018$79,646,000
+57.3%
888,097
+28.3%
0.34%
+57.1%
Q1 2018$50,623,000
+66.1%
691,943
+31.9%
0.22%
+65.9%
Q4 2017$30,479,000
+159.9%
524,768
+100.8%
0.13%
+153.8%
Q3 2017$11,726,000
+148.3%
261,336
+118.5%
0.05%
+147.6%
Q2 2017$4,723,000
+88.8%
119,583
+94.0%
0.02%
+90.9%
Q1 2017$2,501,000
-8.7%
61,640
-9.6%
0.01%
-15.4%
Q4 2016$2,739,000
+395.3%
68,155
+346.2%
0.01%
+333.3%
Q3 2016$553,000
-53.3%
15,276
-62.6%
0.00%
-50.0%
Q2 2016$1,185,00040,8820.01%
Other shareholders
HAEMONETICS CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Millrace Asset Group, Inc. 19,264$1,7262.13%
Parkman Healthcare Partners LLC 88,962$7,969,2161.46%
HEARTLAND ADVISORS INC 256,414$24,435,2741.37%
Riverwater Partners LLC 15,553$1,393,2381.27%
KINGDON CAPITAL MANAGEMENT, L.L.C. 111,100$9,952,3381.15%
Lisanti Capital Growth, LLC 78,425$7,025,3121.11%
Aristotle Capital Boston, LLC 311,666$27,919,0540.90%
ROYCE & ASSOCIATES LP 947,550$84,881,5290.86%
CHASE INVESTMENT COUNSEL CORP 18,770$1,6810.84%
Virtus Investment Advisers, Inc. 13,662$1,223,8420.83%
View complete list of HAEMONETICS CORP shareholders